Thomas J. Farrell - Net Worth and Insider Trading
Thomas J. Farrell Net Worth
The estimated net worth of Thomas J. Farrell is at least $477 dollars as of 2024-09-21. Thomas J. Farrell is the President and CEO of Bellicum Pharmaceuticals Inc and owns about 6,386 shares of Bellicum Pharmaceuticals Inc (BLCM) stock worth over $477. Details can be seen in Thomas J. Farrell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas J. Farrell has not made any transactions after 2015-10-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Thomas J. Farrell
Thomas J. Farrell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas J. Farrell owns 1 companies in total, including Bellicum Pharmaceuticals Inc (BLCM) .
Click here to see the complete history of Thomas J. Farrell’s form 4 insider trades.
Insider Ownership Summary of Thomas J. Farrell
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BLCM | Bellicum Pharmaceuticals Inc | 2015-10-01 | director & President and CEO |
Thomas J. Farrell Latest Holdings Summary
Thomas J. Farrell currently owns a total of 1 stock. Thomas J. Farrell owns 6,386 shares of Bellicum Pharmaceuticals Inc (BLCM) as of October 1, 2015, with a value of $477.
Latest Holdings of Thomas J. Farrell
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BLCM | Bellicum Pharmaceuticals Inc | 2015-10-01 | 6,386 | 0.07 | 477 |
Holding Weightings of Thomas J. Farrell
Thomas J. Farrell Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas J. Farrell has made a total of 0 transactions in Bellicum Pharmaceuticals Inc (BLCM) over the past 5 years. The most-recent trade in Bellicum Pharmaceuticals Inc is the sale of 250 shares on October 1, 2015, which brought Thomas J. Farrell around $36,450.
Insider Trading History of Thomas J. Farrell
- 1
Thomas J. Farrell Trading Performance
Thomas J. Farrell Ownership Network
Thomas J. Farrell Owned Company Details
What does Bellicum Pharmaceuticals Inc do?
Who are the key executives at Bellicum Pharmaceuticals Inc?
Thomas J. Farrell is the director & President and CEO of Bellicum Pharmaceuticals Inc. Other key executives at Bellicum Pharmaceuticals Inc include Chief Development Officer Charity Scripture , Principal Accounting Officer Charles S. Grass , and director & President and CEO Richard A. Fair .
Bellicum Pharmaceuticals Inc (BLCM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Bellicum Pharmaceuticals Inc (BLCM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Bellicum Pharmaceuticals Inc (BLCM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Bellicum Pharmaceuticals Inc (BLCM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bellicum Pharmaceuticals Inc Insider Transactions
Thomas J. Farrell Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas J. Farrell. You might contact Thomas J. Farrell via mailing address: C/o Bellicum Pharmaceuticals, Inc., 2130 W. Holcombe Blvd., Ste. 800, Houston Tx 77030.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
